Form 4: Director Collier Acquires 20,183 Stock Options in Prothena Corp Public LTD CO

Richard T. Collier, a director of Prothena Corp Public LTD CO, acquired 20,183 stock options on May 14, 2025, exercisable for ordinary shares.

Summary

• On May 14, 2025, Richard T. Collier, a director of Prothena Corp Public LTD CO, acquired 20,183 stock options.
• The exercise price of these options is $6.885.
• The options vest on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2026, assuming continuous service as a director.
• The options expire on May 14, 2035.
• Following the transaction, Collier directly owns 20,183 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of stock option acquisition by a director. It doesn't inherently indicate positive or negative performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, transact in their company's stock. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of stock options by a director can align their interests with those of shareholders, as the value of the options increases with the company's stock price.

Key Dates

Keywords

Form 4, Stock Options, Director, Prothena Corp, PRTA, Beneficial Ownership, Collier, Acquisition